Sauvageau Chantal, Dufour-Turbis Christine
a Québec Public Health Institute , Québec , Canada.
b Laval University , Québec , Canada.
Hum Vaccin Immunother. 2016 Jun 2;12(6):1560-5. doi: 10.1080/21645515.2015.1112474. Epub 2015 Nov 10.
Diseases associated with the human papilloma virus (HPV) are particularly common among men who have sex with men (MSM). Unlike heterosexual men, MSM do not benefit from the herd protection provided by the vaccination of girls. In this review, we synthesize the available evidence on HPV vaccination for MSM. We also present the recommendations of the Québec Immunization Committee (CIQ) in this regard, which are: to provide targeted vaccination for MSM up to 26 years of age and in-school vaccination of preadolescent boys since this is the best approach to take to have a real impact on the burden related to HPV in the MSM population and to provide direct protection for all men.
与人类乳头瘤病毒(HPV)相关的疾病在男男性行为者(MSM)中尤为常见。与异性恋男性不同,男男性行为者无法从女孩接种疫苗所提供的群体保护中受益。在本综述中,我们综合了关于男男性行为者HPV疫苗接种的现有证据。我们还介绍了魁北克免疫委员会(CIQ)在这方面的建议,即:为26岁及以下的男男性行为者提供针对性疫苗接种,并对青春期前男孩进行校内疫苗接种,因为这是对男男性行为者群体中与HPV相关负担产生实际影响并为所有男性提供直接保护的最佳方法。